Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Breast Cancer

Free Subscription 25.03.2024 2 Am J Surg 6 BMC Cancer 4 Breast Cancer 1 Breast Cancer (Auckl) 1 Breast Cancer (Dove Med Press) 4 Breast Cancer Res 6 Breast Cancer Res Treat 1 Cancer 1 Cancer Res 4 Clin Breast Cancer 1 Eur J Surg Oncol 3 Eur Radiol 2 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 1 N Engl J Med 1 NPJ Breast Cancer 1 Oncogene 2 PLoS One 1 Pol J Radiol 1 Proc Natl Acad Sci U S A 1 Radiology 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. JIANG K, Ma C, Yang Y, McKevitt E, et al
   Axillary ultrasonography for early-stage invasive breast cancer.
   Am J Surg. 2024 Mar 8:S0002-9610(24)00171-5. doi: 10.1016/j.amjsurg.2024.
   PubMed         Abstract available
   
   
2. ELSHERIF A, Bernard S, Djohan R, Atallah A, et al
   Nipple necrosis rate with submuscular versus prepectoral implant-based reconstruction in nipple sparing mastectomy: Does it differ?
   Am J Surg. 2024;230:57-62.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. REN H, Wang Z, Zhang L, Zhu G, et al
   Clinical significance of low expression of CADM3 in breast cancer and preliminary exploration of related mechanisms.
   BMC Cancer. 2024;24:367.
   PubMed         Abstract available
   
   
4. WANG Y, Men X, Gu Y, Wang H, et al
   Retraction Note: Haplotype analysis on correlation between transcription factor 7-like 2 gene polymorphism and breast cancer risk.
   BMC Cancer. 2024;24:366.
   PubMed        
   
   
5. CHANDRAN G, Tang N, Ngo ELP, Huang S, et al
   Comparing the efficacy of a multi-dimensional breast cancer rehabilitation programme versus a home-based exercise programme during adjuvant cancer treatment.
   BMC Cancer. 2024;24:361.
   PubMed         Abstract available
   
   
6. LOFT LH, Pedersen LH, Bigaard J, Bojesen SE, et al
   Attitudes towards risk-stratified breast cancer screening: a population-based survey among 5,001 Danish women.
   BMC Cancer. 2024;24:347.
   PubMed         Abstract available
   
   
7. WANG ZQ, Wu ZX, Wang ZP, Bao JX, et al
   Pan-cancer analysis of NUP155 and validation of its role in breast cancer cell proliferation, migration, and apoptosis.
   BMC Cancer. 2024;24:353.
   PubMed         Abstract available
   
   
8. OPUTA CH, Peters E, Otovwe A
   Effect of educational intervention on the knowledge, attitude and practice of breast self-examination among female students at a private university in Southern Nigeria.
   BMC Cancer. 2024;24:355.
   PubMed         Abstract available
   
   

   
   Breast Cancer

9. NARUI K, Satake T, Ishikawa T, Muto M, et al
   Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer.
   Breast Cancer. 2024 Mar 21. doi: 10.1007/s12282-024-01561.
   PubMed         Abstract available
   
   
10. HASHIMOTO K, Ochiya T, Shimomura A
    Liquid biopsy using non-coding RNAs and extracellular vesicles for breast cancer management.
    Breast Cancer. 2024 Mar 21. doi: 10.1007/s12282-024-01562.
    PubMed         Abstract available
    
    
11. VO K, Ladbury C, Yoon S, Bazan J, et al
    Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
    Breast Cancer. 2024 Mar 20. doi: 10.1007/s12282-024-01560.
    PubMed         Abstract available
    
    
12. OHMURA H, Hanamura F, Okumura Y, Ando Y, et al
    Liquid biopsy for breast cancer and other solid tumors: a review of recent advances.
    Breast Cancer. 2024 Mar 16. doi: 10.1007/s12282-024-01556.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Auckl)

13. FRICK EA, Kristjansdottir K, Ragnarsdottir S, Vilhjalmsson AI, et al
    MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast Cancer.
    Breast Cancer (Auckl). 2024;18:11782234241234771.
    PubMed         Abstract available
    
    

    
    Breast Cancer (Dove Med Press)

14. RANGEL N, Sanchez IL, Valbuena DS, Rondon-Lagos M, et al
    ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERalpha Status in Breast Cancer.
    Breast Cancer (Dove Med Press). 2024;16:127-139.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res

15. HAMILTON AM, Walens A, Van Alsten SC, Olsson LT, et al
    BIRC5 expression by race, age and clinical factors in breast cancer patients.
    Breast Cancer Res. 2024;26:50.
    PubMed         Abstract available
    
    
16. MCCLELLAN JC, Li JL, Gao G, Huo D, et al
    Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status.
    Breast Cancer Res. 2024;26:51.
    PubMed         Abstract available
    
    
17. LEE J, Lee G, Park HS, Jeong BK, et al
    Factors associated with engraftment success of patient-derived xenografts of breast cancer.
    Breast Cancer Res. 2024;26:49.
    PubMed         Abstract available
    
    
18. HU R, Cao Y, Wang Y, Zhao T, et al
    TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via beta1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
    Breast Cancer Res. 2024;26:48.
    PubMed         Abstract available
    
    

    
    Breast Cancer Res Treat

19. BAHL M, Deng B
    Impact of pre-operative MRI on surgical management of screening digital breast tomosynthesis-detected invasive lobular carcinoma.
    Breast Cancer Res Treat. 2024;204:397-405.
    PubMed         Abstract available
    
    
20. COBLEIGH MA, Layng KV, Mauer E, Mahon B, et al
    Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.
    Breast Cancer Res Treat. 2024;204:407-414.
    PubMed         Abstract available
    
    
21. AI D, Turashvili G, Gjeorgjievski SG, Wang Q, et al
    Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff.
    Breast Cancer Res Treat. 2024;204:415-422.
    PubMed         Abstract available
    
    
22. KONTOS M, Kanavidis P, Kuhn T, Masannat Y, et al
    Targeted axillary dissection: worldwide variations in clinical practice.
    Breast Cancer Res Treat. 2024;204:389-396.
    PubMed         Abstract available
    
    
23. AUGUSTINSSON A, Loman N, Ehrencrona H
    Retrospective genetic testing (Traceback) in women with early-onset breast cancer after revised national guidelines: a clinical implementation study.
    Breast Cancer Res Treat. 2024 Mar 16. doi: 10.1007/s10549-024-07288.
    PubMed         Abstract available
    
    
24. NASIRI N, Hu M, Hajizadeh M
    Trends in socioeconomic inequalities in breast cancer mortality in Canada: 1992-2019.
    Breast Cancer Res Treat. 2024 Mar 19. doi: 10.1007/s10549-024-07277.
    PubMed         Abstract available
    
    

    
    Cancer

25. VANNIER AGL, Dhungana A, Zhao F, Chen N, et al
    Validation of the RSClin risk calculator in the National Cancer Data Base.
    Cancer. 2024;130:1210-1220.
    PubMed         Abstract available
    
    

    
    Cancer Res

26. ZHANG M, Zhou K, Wang Z, Liu T, et al
    A subpopulation of luminal progenitors secretes pleiotrophin to promote angiogenesis and metastasis in inflammatory breast cancer.
    Cancer Res. 2024 Mar 20. doi: 10.1158/0008-5472.CAN-23-2640.
    PubMed         Abstract available
    
    

    
    Clin Breast Cancer

27. FASOLA CE, Graham E, Sha W, Schepel CR, et al
    Assessment of Postmastectomy Radiation Therapy Receipt by Age and Association With Outcomes in Women With Breast Cancer.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00057.
    PubMed         Abstract available
    
    
28. DEBIEN V, Agostinetto E, Bruzzone M, Ceppi M, et al
    The Impact of Initial Tumor Response on Survival Outcomes of Patients With HER2-Positive Advanced Breast Cancer Treated With Docetaxel, Trastuzumab, and Pertuzumab: An Exploratory Analysis of the CLEOPATRA Trial.
    Clin Breast Cancer. 2024 Feb 21:S1526-8209(24)00050.
    PubMed         Abstract available
    
    
29. WANG T, Wang J, Zhao W, Pan Y, et al
    Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy.
    Clin Breast Cancer. 2024 Feb 28:S1526-8209(24)00054.
    PubMed         Abstract available
    
    
30. JIANG J, Li L, Yin G, Luo H, et al
    A Molecular Typing Method for Invasive Breast Cancer by Serum Raman Spectroscopy.
    Clin Breast Cancer. 2024 Feb 16:S1526-8209(24)00048.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

31. DI LENA E, Wong SM, Iny E, Mashal S, et al
    Oncologic safety of breast conserving surgery after neoadjuvant chemotherapy in patients with multiple ipsilateral breast cancer: A retrospective multi-institutional cohort study.
    Eur J Surg Oncol. 2024;50:108266.
    PubMed         Abstract available
    
    

    
    Eur Radiol

32. MAO C, Hu L, Jiang W, Qiu Y, et al
    Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models.
    Eur Radiol. 2024;34:2546-2559.
    PubMed         Abstract available
    
    
33. XU Z, Lin Y, Huo J, Gao Y, et al
    A bimodal nomogram as an adjunct tool to reduce unnecessary breast biopsy following discordant ultrasonic and mammographic BI-RADS assessment.
    Eur Radiol. 2024;34:2608-2618.
    PubMed         Abstract available
    
    
34. VEDANTHAM S
    Contrast-enhanced breast computed tomography: can lymph node metastasis be predicted from primary tumor?
    Eur Radiol. 2024;34:2574-2575.
    PubMed        
    
    

    
    Int J Radiat Oncol Biol Phys

35. KIROVA YM, Loap P
    Improving the Treatment of Brain Metastases in HER2-Positive Breast Cancers: Eternal Dream or Reality? Results of the NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial and Future Directions.
    Int J Radiat Oncol Biol Phys. 2024;118:1402-1403.
    PubMed        
    
    
36. SHEVA K, Chowdhury SR, Kravchenko-Balasha N, Meirovitz A, et al
    Molecular changes in breast cancer induced by radiation therapy.
    Int J Radiat Oncol Biol Phys. 2024 Mar 18:S0360-3016(24)00435.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

37. SALTBAEK L, Bidstrup PE, Karlsen RV, Hoeg BL, et al
    Nurse-Led Individualized Follow-Up Versus Regular Physician-Led Visits After Early Breast Cancer (MyHealth): A Phase III Randomized, Controlled Trial.
    J Clin Oncol. 2024 Mar 18:JCO2301447. doi: 10.1200/JCO.23.01447.
    PubMed         Abstract available
    
    
38. MAYER EL, Ren Y, Wagle N, Mahtani R, et al
    PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Bre
    J Clin Oncol. 2024 Mar 21:JCO2301940. doi: 10.1200/JCO.23.01940.
    PubMed         Abstract available
    
    

    
    N Engl J Med

39. SLAMON D, Lipatov O, Nowecki Z, McAndrew N, et al
    Ribociclib plus Endocrine Therapy in Early Breast Cancer.
    N Engl J Med. 2024;390:1080-1091.
    PubMed         Abstract available
    
    

    
    NPJ Breast Cancer

40. VAN BAELEN K, Van Cauwenberge J, Maetens M, Beck G, et al
    Reporting on invasive lobular breast cancer in clinical trials: a systematic review.
    NPJ Breast Cancer. 2024;10:23.
    PubMed         Abstract available
    
    

    
    Oncogene

41. RUSSO GC, Crawford AJ, Clark D, Cui J, et al
    E-cadherin interacts with EGFR resulting in hyper-activation of ERK in multiple models of breast cancer.
    Oncogene. 2024 Mar 20. doi: 10.1038/s41388-024-03007.
    PubMed         Abstract available
    
    

    
    PLoS One

42. BELACHEW EB, Desta AF, Mulu A, Deneke DB, et al
    High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
    PLoS One. 2024;19:e0298583.
    PubMed         Abstract available
    
    
43. OTTO AK, Prinsloo S, Natori A, Wagner RW, et al
    Impact of COVID-19-related experiences on health-related quality of life in cancer survivors in the United States.
    PLoS One. 2024;19:e0297077.
    PubMed         Abstract available
    
    

    
    Pol J Radiol

44. EBAID NY, Assy MM, Eldin AMA
    Diagnostic validity of abbreviated breast MRI in the diagnosis of breast cancer: a comparative study to the full breast MRI protocol using BI-RADS.
    Pol J Radiol. 2024;89:e80-e87.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

45. WANG D, Tang M, Zhang P, Yang K, et al
    Activation of ERbeta hijacks the splicing machinery to trigger R-loop formation in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2306814121.
    PubMed         Abstract available
    
    

    
    Radiology

46. DONNELLY J, Moffett L, Barnett AJ, Trivedi H, et al
    AsymMirai: Interpretable Mammography-based Deep Learning Model for 1-5-year Breast Cancer Risk Prediction.
    Radiology. 2024;310:e232780.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

47. HUIJSKENS S, Granton P, Fremeijer K, van Wanrooij C, et al
    Clinical practicality and patient performance for surface-guided automated VMAT gating for DIBH breast cancer radiotherapy.
    Radiother Oncol. 2024 Mar 14:110229. doi: 10.1016/j.radonc.2024.110229.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.